Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
480 participants
OBSERVATIONAL
2020-06-04
2030-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Current disease management strategies will be evaluated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Understanding Blood Pressure Changes After Birth
NCT05137808
Management of Postpartum Preeclampsia
NCT05775744
Left Ventricular and Endothelial Function in Preeclampsia
NCT00201500
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
NCT06187012
Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study
NCT02333240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection for parameters of organ damage (cardiac and renal blood markers)
Blood results will be taken out of next routine venipuncture. Routinely collected standard parameters are a blood count, chemistry panel including renal parameters and electrolytes, lipid profile and a HbA1c as well as albumin/creatinine and protein/creatinine ratio in urine.
Data collection for blood pressure (BP)
Clinic blood pressure and 24hour BP Measurements
Home-based blood pressure management (substudy)
Subjects participating in home-based blood pressure management via telemonitoring will receive a free HekaHealth application (App) for the structured assessment of HBPM.
Biomarker Profiles (substudy)
Substudy where possible cardiac, renal and pregnancy related biomarkers will be additionally analyzed. The following biomarkers will be analyzed: N terminal (NT)-proBNP, Troponin, elevated mid-regional pro-atrial natriuretic peptide (ANP), elevated mid-regional pro adrenomedullin (ADM), soluble fms-like tyrosine kinase (sFlt-1), and placenta growth factor (PlGF).
Data collection on patient reported outcomes
Data collection on patient reported outcomes (Questionnaire EQ-5D, Questionnaire for App based monitoring )
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* postpartum hypertension (blood pressure measurements of systolic ≥140 and/or diastolic ≥ 90mmHg or antihypertensive therapy within the first 14 days after delivery)
* women with preexisting hypertension or
* women on antihypertensive medication
Exclusion Criteria
* lack of consent to participate in the study, language barriers or lack of general understanding
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thenral Socrates, Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Medical Outpatient Department and Hypertension Clinic, University Hospital BaselUni
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical Outpatient Department and Hypertension Clinic, University Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-00736; me20Burkard
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.